Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
Vaccine|July 4, 2012
Cost-effectiveness of pertussis booster vaccination in the NetherlandsMark H Rozenbaum, Elisabetta De Cao, Maarten J PostmaExpert Review of Vaccines|February 22, 2011
Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccinationMark H Rozenbaum, Cornelis Boersma, Maarten J Postma, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 30, 2022
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid CardiomyopathyMark H Rozenbaum, Diana Tran, Rahul Bhambri, et al.Quality & Safety in Health Care|December 4, 2009
Use of colour-coded labels for intravenous high-risk medications and lines to improve patient safetyN Porat, Y Bitan, D Shefi, et al.Vaccines|February 26, 2026
A Multi-Country Comparison of Number Needed to Vaccinate for PCV20 and PCV15 in InfantsEuan Dawson, Maria J Tort, An Ta, et al.Vaccines|May 26, 2026
Correction: Dawson et al. A Multi-Country Comparison of Number Needed to Vaccinate for PCV20 and PCV15 in Infants. Vaccines 2026, 14, 188Euan Dawson, Maria J Tort, An Ta, et al.Applied Health Economics and Health Policy|July 19, 2018
The Impact of Patent Expiry on Drug Prices: A Systematic Literature ReviewGerard T Vondeling, Qi Cao, Maarten J Postma, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 1, 1989
Intra-uterine device failure: relation with drug useE Papiernik, H Rozenbaum, P Amblard, et al.Expert Review of Vaccines|July 31, 2008
Cost-effectiveness of varicella vaccination programs: an update of the literatureMark H Rozenbaum, Albert Jan van Hoek, Stefan Vegter, et al.Vaccine|January 21, 2010
Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar)Mark H Rozenbaum, Albert Jan van Hoek, Eelko Hak, et al.Pageof 8